Filing and period context
Important identification mismatch: The request names T3 Defense Inc. and 2020 Q3, but the supplied filing identifies Brilliant Acquisition Corporation, a blank-check company, and reports the quarter ended March 31, 2021. The filing is signed October 12, 2021. This summary reflects the supplied text, not the requested company or period.
Brilliant was formed to pursue a business combination, with a stated focus on Asia-Pacific businesses. It had not begun operating activities or generated revenue as of March 31, 2021. The interim financial statements are unaudited.
Financial results and position
| Metric | Three months ended March 31, 2021 | Comparable 2020 period |
|---|---|---|
| Revenue | $0 | $0 |
| Operating costs | $78,411 | $124 |
| Net loss | $20,373 | $124 |
| Operating cash flow | $(85,864) | $(124) |
2021 net loss included $56,901 of noncash income from a decline in the fair value of derivative warrant liabilities and $1,137 of trust-account interest income. The MD&A separately states $567,901 for the warrant-liability adjustment, inconsistent with the financial statements; the filing text does not provide a clear reconciliation. Per-share loss is shown as $(0.00) on the statements and $(0.01) in a note.
At March 31, 2021, total assets were $46.66 million, including $46.00 million in the trust account and $626,953 in cash outside it. Working capital was $320,980. Total liabilities were $525,261, including a $243,833 related-party promissory note and $190,733 of derivative warrant liabilities. There was no long-term debt reported. Redeemable shares of $46.00 million were presented as temporary equity, not shareholders’ equity. Total shareholders’ equity was $134,435.
Margins are not meaningful because the company had no operating revenue. Cash outside the trust account fell by $85,864 during the quarter. Trust assets were invested primarily in U.S. Treasury money-market funds; management stated it saw no material interest-rate risk from these short-term investments.
Changes, outlook, and risks
- Operating costs rose from $124 to $78,411 year over year; net loss increased to $20,373. The 2021 result was partly offset by the warrant fair-value gain.
- The company had until June 25, 2021 to complete a business combination, with up to three three-month extensions. Subsequent to quarter-end, the sponsor funded two $460,000 extension deposits, extending the deadline to December 25, 2021. These are subsequent events, not March 31 cash or liabilities.
- Management believed available cash would meet needs through the business-combination deadline, but sponsor and affiliate working-capital loans were discretionary, not committed. If no combination is completed within the permitted period, public shares are to be redeemed and the company wound up; warrants and rights may expire worthless.
- COVID-19 could adversely affect the company’s financial position or target search, but management said the impact was not readily determinable. A successful combination was not assured; additional financing or share issuance could be needed and could dilute investors.
- Management reported ineffective internal control over financial reporting at March 31, 2021 because of a material weakness in accounting for the IPO warrants and redeemable shares. The company described remediation efforts but gave no assurance they would be effective. The filing also refers to a restatement in its controls discussion.
- The filing states that the company had not filed all required reports during the preceding 12 months. This is a compliance concern to investigate.
Investor verification priorities
- Confirm the issuer and reporting period: the supplied document is for Brilliant Acquisition Corporation, not T3 Defense Inc., and covers Q1 2021, not Q3 2020.
- Check the SEC filing version and any amendments or restated statements, including the filing’s stated reporting delinquency and October 2021 filing date.
- Reconcile the $56,901 versus $567,901 warrant fair-value adjustment and the inconsistent per-share loss disclosures.
- Verify extension-loan deposits, the final business-combination deadline, related-party note terms, and current liquidity outside the trust account.
- Review the material weakness, restatement disclosures, remediation status, and any subsequent business-combination or liquidation outcome.